Brief: Vitura Health And Pharmala Biotech Establish A 50:50 Joint Venture, Called Cortexa
02/05/2023 02:08
May 2 (Reuters) - VITURA HEALTH LTD VIT.AX :
* VITURA HEALTH AND PHARMALA BIOTECH ESTABLISHED A 50:50
JOINT
VENTURE, CALLED CORTEXA
Source text for Eikon: ID:nASX2wN55h
Further company coverage: MDMA.CD
(Reporting by Archishma Iyer)
((Archishma.Iyer@thomsonreuters.com;))
Recent news on Vitura Health
See all newsAustralia's Vitura Health gains on quarterly profit jump
Australia's Vitura Health hits record low on FY27 revenue warning
Brief: Vitura Health Says Bupa To Redirect All International-Member Telehealth Referrals
Australia's Vitura Health slips after company flags FY27 revenue impact
Brief: Vitura Health Appoints Tom Howitt As Interim CFO Effective Immediately